Literature DB >> 3156645

Medroxyprogesterone acetate does not protect human bone marrow progenitor cells exposed to adriamycin in vitro.

G E Umbach, G Spitzer, B Drewinko, G Gercovich, G Hortobagyi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156645     DOI: 10.1007/bf01807655

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  8 in total

1.  Colony stimulating factor augmentation in human placental conditioned medium.

Authors:  D S Verma; G Spitzer; M Beran; A R Zander; K B McCredie; K A Dicke
Journal:  Exp Hematol       Date:  1980-08       Impact factor: 3.084

2.  Combined cytotoxic and progestogen therapy for advanced breast cancer.

Authors:  R D Rubens; R H Begent; R K Knight; S A Sexton; J L Hayward
Journal:  Cancer       Date:  1978-10       Impact factor: 6.860

3.  [Myelopoietic effect of medroxyprogesterone acetate at high parenteral doses in the cancer patient].

Authors:  F Gustavo Gercovich; E Morgenfeld; M Dragosky; H Murro; M Sorrentino; A Presman; R E Martínez
Journal:  Sangre (Barc)       Date:  1982

4.  5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.

Authors:  H P Lohrmann; K A Lepp; W Schreml
Journal:  J Natl Cancer Inst       Date:  1982-04       Impact factor: 13.506

5.  Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer.

Authors:  H P Lohrmann; W Schreml; M Lang; M Betzler; T M Fliedner; H Heimpel
Journal:  Br J Haematol       Date:  1978-11       Impact factor: 6.998

6.  Normalization of in vitro sensitivity testing of human tumor clonogenic cells.

Authors:  V Hug; H Thames; G R Blumenschein; G Spitzer; B Drewinko
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

7.  The pharmacokinetics of high-dose medroxyprogesterone acetate (MPA) in the therapy of advanced breast cancer.

Authors:  H C Blossey; H H Bartsch; D Kanne; J Koebberling; G A Nagel
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 8.  High-dose medroxyprogesterone acetate (MPA) treatment in advanced breast cancer. A review.

Authors:  F Ganzina
Journal:  Tumori       Date:  1979-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.